Marta Żołnowska

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 887 citations

Medicine, Neurology, Pharmacology +9

Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial

Orrin Devinsky, Rima Nabbout, Ian Miller et al. · Epilepsia · 2018 · 270 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex

Elizabeth A. Thiele, E. Martina Bebin, Hari Bhathal et al. · JAMA Neurology · 2020 · 262 citations · Full text

Medicine, Neurology, Pharmacology +14

Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial

Ingrid E. Scheffer, Jonathan J. Halford, Ian Miller et al. · Epilepsia · 2021 · 91 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome (<scp>ELEKTRA</scp>)

Cecil D. Hahn, Yuwu Jiang, Vicente Villanueva et al. · Epilepsia · 2022 · 76 citations · Full text

Medicine, Pediatrics, Pharmacology +17